Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia Considers Delay In H1N1 Vaccine Distribution To Next Winter

This article was originally published in PharmAsia News

Executive Summary

The Australian government has decided to be cautious in releasing the millions of doses of H1N1 flu vaccine it has ordered from drug maker CSL. The vaccine is currently in clinical trials and reportedly proceeding smoothly through the process. CSL says its vaccine could be ready for distribution by the end of August, but the government could delay distributing from its stockpile until the nation's next winter season. The government already has ruled out early distribution to the elderly, patients with chronic illnesses and others considered vulnerable. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel